ATE221785T1 - Verfahren zum selektiven methioninentzug für maligne säugetierzellen - Google Patents

Verfahren zum selektiven methioninentzug für maligne säugetierzellen

Info

Publication number
ATE221785T1
ATE221785T1 AT95906124T AT95906124T ATE221785T1 AT E221785 T1 ATE221785 T1 AT E221785T1 AT 95906124 T AT95906124 T AT 95906124T AT 95906124 T AT95906124 T AT 95906124T AT E221785 T1 ATE221785 T1 AT E221785T1
Authority
AT
Austria
Prior art keywords
methionine
mammal
malignant
withdrawal
mtase
Prior art date
Application number
AT95906124T
Other languages
English (en)
Inventor
Tsutomu Nobori
Dennis A Carson
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Application granted granted Critical
Publication of ATE221785T1 publication Critical patent/ATE221785T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/51Lyases (4)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/527Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95906124T 1993-12-29 1994-12-22 Verfahren zum selektiven methioninentzug für maligne säugetierzellen ATE221785T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/176,413 US5571510A (en) 1993-12-29 1993-12-29 Method for selective methionine starvation of malignant cells in mammals
PCT/US1994/014919 WO1995017908A1 (en) 1993-12-29 1994-12-22 Method for selective methionine starvation of malignant cells in mammals

Publications (1)

Publication Number Publication Date
ATE221785T1 true ATE221785T1 (de) 2002-08-15

Family

ID=22644262

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95906124T ATE221785T1 (de) 1993-12-29 1994-12-22 Verfahren zum selektiven methioninentzug für maligne säugetierzellen

Country Status (17)

Country Link
US (1) US5571510A (de)
EP (1) EP0805690B1 (de)
JP (1) JPH09507754A (de)
CN (1) CN1143325A (de)
AT (1) ATE221785T1 (de)
AU (1) AU694161B2 (de)
CA (1) CA2180262A1 (de)
CZ (1) CZ291281B6 (de)
DE (1) DE69431167T2 (de)
HU (1) HU221341B1 (de)
NO (1) NO962714L (de)
NZ (1) NZ278271A (de)
PL (1) PL182298B1 (de)
RO (1) RO117542B1 (de)
RU (1) RU2153885C2 (de)
TJ (1) TJ294B (de)
WO (1) WO1995017908A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5891704A (en) * 1992-11-19 1999-04-06 Anticancer, Inc. Method to produce high levels of methioninase
US6461851B1 (en) 1992-11-19 2002-10-08 Anticancer, Inc. High expression modules containing two or more tandem copies of a methioninase encoding sequence
US6911309B2 (en) * 1993-12-29 2005-06-28 The Regents Of The University Of Californnia Nucleic acids encoding MTAse
US6870037B1 (en) * 1995-07-03 2005-03-22 Arch Development Corporation Methylthioadenosine phosphorylase compositions and methods of use in the diagnosis and treatment of proliferative disorders
US5861154A (en) * 1995-10-30 1999-01-19 Shionogi & Co., Ltd. Recombinant L-methionine γ-lyase
AU2001280155A1 (en) * 2000-09-05 2002-03-22 Shionogi And Co., Ltd. L-methionine gamma-lyase with modified function
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
US20040127435A1 (en) * 2002-08-02 2004-07-01 Regents Of The University Of California Uses for inhibitors of inosine monophosphate dehydrogenase
CA2516191A1 (en) * 2003-02-14 2004-09-02 Salmedix, Inc Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers
US20110002978A1 (en) 2003-06-17 2011-01-06 Harrison Roger G Enzyme prodrug cancer therapy selectively targeted to tumor cells or tumor vasculature and methods of production and use thereof
WO2009032057A2 (en) 2007-08-29 2009-03-12 Adam Lubin Method for the selective therapy of disease
WO2009140007A2 (en) * 2008-04-14 2009-11-19 Ats Medical, Inc. Tool for implantation of replacement heart valve
US9987241B2 (en) 2014-09-25 2018-06-05 The Board Of Regents Of The University Of Oklahoma Enzyme conjugate and prodrug cancer therapy
WO2020032951A1 (en) 2018-08-09 2020-02-13 The Board Of Regents Of The University Of Oklahoma Antimalarial enzyme conjugates, kits containing same, and methods of producing and using same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4179337A (en) * 1973-07-20 1979-12-18 Davis Frank F Non-immunogenic polypeptides
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides

Also Published As

Publication number Publication date
RO117542B1 (ro) 2002-04-30
CA2180262A1 (en) 1995-07-06
EP0805690A4 (de) 1999-05-12
HU9601695D0 (en) 1996-08-28
CN1143325A (zh) 1997-02-19
DE69431167D1 (de) 2002-09-12
PL182298B1 (pl) 2001-12-31
AU1445995A (en) 1995-07-17
DE69431167T2 (de) 2003-04-17
TJ294B (en) 2001-03-30
NO962714L (no) 1996-08-26
AU694161B2 (en) 1998-07-16
NO962714D0 (no) 1996-06-27
US5571510A (en) 1996-11-05
JPH09507754A (ja) 1997-08-12
EP0805690A1 (de) 1997-11-12
HUT75070A (en) 1997-04-28
WO1995017908A1 (en) 1995-07-06
CZ291281B6 (cs) 2003-01-15
HU221341B1 (en) 2002-09-28
EP0805690B1 (de) 2002-08-07
NZ278271A (en) 2001-07-27
CZ186996A3 (en) 1996-12-11
RU2153885C2 (ru) 2000-08-10

Similar Documents

Publication Publication Date Title
ATE221785T1 (de) Verfahren zum selektiven methioninentzug für maligne säugetierzellen
ATE124694T1 (de) Chinazolinderivate um die antitumorwirkung zu verbessern.
ES8701496A1 (es) Procedimiento para preparar una sal de 9-(1, 3-dihidroxi-2-propoximetil)-guanina farmaceuticamente aceptable
GR3018029T3 (en) New protein-polycation conjugates.
MY103665A (en) Anthracycline glycosides
AU546063B2 (en) Drawer and slide
GB2226718B (en) Aligning two audio signals in time,for editing
ES471900A1 (es) Procedimiento para preparar oxialquilenos polimeros
IL97233A0 (en) Rebeccamycin analogs,their production and pharmaceutical compositions containing them
BE854580A (fr) Procede de soutenement d'excavations et de galeries, notamment dans l'industrie miniere et la construction de tunnels.
IT8022232A0 (it) Tetto scorrevole rigido, in particolare di vetro, per un veicolo provvisto di un'apertura sul tetto.
USD285866S (en) Combined pocket tool case and key holder
YU49777A (en) Track for single-rail cable railways for operation in an underground mine
USD291662S (en) Track type drafting machine
NZ217842A (en) Promoter arrangement for streptomyces vectors
FR2577310B1 (fr) Banc de chariot de sole, en matiere refractaire, pour fours tunnels a chariots.
SE9100848L (sv) Kapell, avsett foeretraedesvis foer baatar
ES1000679U (es) Estuche porta-cintas de video
Kidd NKK, National Deal Benefits Seen on Both Sides of Pacific
NEIMITZ On a certain dynamic crack problem in elastic and elastic-plastic media
ES1032031U (es) Soporte publicitario.
IT8384978A0 (it) Dispositivo atto alla visione nella direzione di marcia per corridori ciclisti.
ES452951A2 (es) Perfeccionamientos en sistemas no convencionales de trans- portes ferroviario.
SE8803362L (sv) Skyltstaell
ES287265U (es) Expositor para cinturones de vestir

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties